The recent earnings highlights for Sarepta Therapeutics (SRPT) are as follows:
In the fourth quarter, the company earned $45.66 million as compared to a loss of -$109.24 million during the same period the previous year. The Earnings Per Share (EPS) were $0.47 in contrast to -$1.24 in the corresponding period of the previous year.
Upon excluding some elements, the adjusted earnings reported by Sarepta Therapeutics for the term were $86.58 million or $0.82 per share. This earning outperformed the analysts' projection of $0.01 per share.
Moreover, the revenue for the fourth quarter stood at $396.78 million, showing a significant increase from $258.43 million registered during the same period in the preceding year.
